The global market for CGT Drugs was valued at US$ 4815 million in the year 2024 and is projected to reach a revised size of US$ 7341 million by 2031, growing at a CAGR of 6.3% during the forecast period.

CGT Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for CGT Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CGT Drugs.

The CGT Drugs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CGT Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CGT Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of CGT Drugs Market Report

Report Metric	Details
Report Name	CGT Drugs Market
Accounted market size in year	US$ 4815 million
Forecasted market size in 2031	US$ 7341 million
CAGR	6.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CAR-T Therapy Viral Vector Therapy Stem Cell Therapy Oncolytic Virus Therapy
Segment by Application	Rare Disease Tumor Disease Eye Disease Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Janssen Biotech, Celgene Corporation, Juno Therapeutics, Kite Pharma, Novartis, Spark Therapeutics, Amgen, Bluebird Bio, GSK, Orchard Therapeutics, Sequoia, Fosun Kite Biotechnology, Sunway Biotech, SiBiono
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CGT Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CGT Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is CGT Drugs Market growing?

Ans: The CGT Drugs Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the CGT Drugs Market size in 2031?

Ans: The CGT Drugs Market size in 2031 will be US$ 7341 million.

Who are the main players in the CGT Drugs Market report?

Ans: The main players in the CGT Drugs Market are Janssen Biotech, Celgene Corporation, Juno Therapeutics, Kite Pharma, Novartis, Spark Therapeutics, Amgen, Bluebird Bio, GSK, Orchard Therapeutics, Sequoia, Fosun Kite Biotechnology, Sunway Biotech, SiBiono

What are the Application segmentation covered in the CGT Drugs Market report?

Ans: The Applications covered in the CGT Drugs Market report are Rare Disease, Tumor Disease, Eye Disease, Others

What are the Type segmentation covered in the CGT Drugs Market report?

Ans: The Types covered in the CGT Drugs Market report are CAR-T Therapy, Viral Vector Therapy, Stem Cell Therapy, Oncolytic Virus Therapy

1 CGT Drugs Market Overview

1.1 Product Definition

1.2 CGT Drugs by Type

1.2.1 Global CGT Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 CAR-T Therapy

1.2.3 Viral Vector Therapy

1.2.4 Stem Cell Therapy

1.2.5 Oncolytic Virus Therapy

1.3 CGT Drugs by Application

1.3.1 Global CGT Drugs Market Value by Application (2024 VS 2031)

1.3.2 Rare Disease

1.3.3 Tumor Disease

1.3.4 Eye Disease

1.3.5 Others

1.4 Global CGT Drugs Market Size Estimates and Forecasts

1.4.1 Global CGT Drugs Revenue 2020-2031

1.4.2 Global CGT Drugs Sales 2020-2031

1.4.3 Global CGT Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 CGT Drugs Market Competition by Manufacturers

2.1 Global CGT Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global CGT Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global CGT Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of CGT Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of CGT Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of CGT Drugs, Product Type & Application

2.7 Global Key Manufacturers of CGT Drugs, Date of Enter into This Industry

2.8 Global CGT Drugs Market Competitive Situation and Trends

2.8.1 Global CGT Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest CGT Drugs Players Market Share by Revenue

2.8.3 Global CGT Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global CGT Drugs Market Scenario by Region

3.1 Global CGT Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global CGT Drugs Sales by Region: 2020-2031

3.2.1 Global CGT Drugs Sales by Region: 2020-2025

3.2.2 Global CGT Drugs Sales by Region: 2026-2031

3.3 Global CGT Drugs Revenue by Region: 2020-2031

3.3.1 Global CGT Drugs Revenue by Region: 2020-2025

3.3.2 Global CGT Drugs Revenue by Region: 2026-2031

3.4 North America CGT Drugs Market Facts & Figures by Country

3.4.1 North America CGT Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America CGT Drugs Sales by Country (2020-2031)

3.4.3 North America CGT Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe CGT Drugs Market Facts & Figures by Country

3.5.1 Europe CGT Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe CGT Drugs Sales by Country (2020-2031)

3.5.3 Europe CGT Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific CGT Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific CGT Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific CGT Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific CGT Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America CGT Drugs Market Facts & Figures by Country

3.7.1 Latin America CGT Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America CGT Drugs Sales by Country (2020-2031)

3.7.3 Latin America CGT Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa CGT Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa CGT Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa CGT Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa CGT Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global CGT Drugs Sales by Type (2020-2031)

4.1.1 Global CGT Drugs Sales by Type (2020-2025)

4.1.2 Global CGT Drugs Sales by Type (2026-2031)

4.1.3 Global CGT Drugs Sales Market Share by Type (2020-2031)

4.2 Global CGT Drugs Revenue by Type (2020-2031)

4.2.1 Global CGT Drugs Revenue by Type (2020-2025)

4.2.2 Global CGT Drugs Revenue by Type (2026-2031)

4.2.3 Global CGT Drugs Revenue Market Share by Type (2020-2031)

4.3 Global CGT Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global CGT Drugs Sales by Application (2020-2031)

5.1.1 Global CGT Drugs Sales by Application (2020-2025)

5.1.2 Global CGT Drugs Sales by Application (2026-2031)

5.1.3 Global CGT Drugs Sales Market Share by Application (2020-2031)

5.2 Global CGT Drugs Revenue by Application (2020-2031)

5.2.1 Global CGT Drugs Revenue by Application (2020-2025)

5.2.2 Global CGT Drugs Revenue by Application (2026-2031)

5.2.3 Global CGT Drugs Revenue Market Share by Application (2020-2031)

5.3 Global CGT Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Janssen Biotech

6.1.1 Janssen Biotech Company Information

6.1.2 Janssen Biotech Description and Business Overview

6.1.3 Janssen Biotech CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Janssen Biotech CGT Drugs Product Portfolio

6.1.5 Janssen Biotech Recent Developments/Updates

6.2 Celgene Corporation

6.2.1 Celgene Corporation Company Information

6.2.2 Celgene Corporation Description and Business Overview

6.2.3 Celgene Corporation CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Celgene Corporation CGT Drugs Product Portfolio

6.2.5 Celgene Corporation Recent Developments/Updates

6.3 Juno Therapeutics

6.3.1 Juno Therapeutics Company Information

6.3.2 Juno Therapeutics Description and Business Overview

6.3.3 Juno Therapeutics CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Juno Therapeutics CGT Drugs Product Portfolio

6.3.5 Juno Therapeutics Recent Developments/Updates

6.4 Kite Pharma

6.4.1 Kite Pharma Company Information

6.4.2 Kite Pharma Description and Business Overview

6.4.3 Kite Pharma CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Kite Pharma CGT Drugs Product Portfolio

6.4.5 Kite Pharma Recent Developments/Updates

6.5 Novartis

6.5.1 Novartis Company Information

6.5.2 Novartis Description and Business Overview

6.5.3 Novartis CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Novartis CGT Drugs Product Portfolio

6.5.5 Novartis Recent Developments/Updates

6.6 Spark Therapeutics

6.6.1 Spark Therapeutics Company Information

6.6.2 Spark Therapeutics Description and Business Overview

6.6.3 Spark Therapeutics CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Spark Therapeutics CGT Drugs Product Portfolio

6.6.5 Spark Therapeutics Recent Developments/Updates

6.7 Amgen

6.7.1 Amgen Company Information

6.7.2 Amgen Description and Business Overview

6.7.3 Amgen CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Amgen CGT Drugs Product Portfolio

6.7.5 Amgen Recent Developments/Updates

6.8 Bluebird Bio

6.8.1 Bluebird Bio Company Information

6.8.2 Bluebird Bio Description and Business Overview

6.8.3 Bluebird Bio CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Bluebird Bio CGT Drugs Product Portfolio

6.8.5 Bluebird Bio Recent Developments/Updates

6.9 GSK

6.9.1 GSK Company Information

6.9.2 GSK Description and Business Overview

6.9.3 GSK CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 GSK CGT Drugs Product Portfolio

6.9.5 GSK Recent Developments/Updates

6.10 Orchard Therapeutics

6.10.1 Orchard Therapeutics Company Information

6.10.2 Orchard Therapeutics Description and Business Overview

6.10.3 Orchard Therapeutics CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Orchard Therapeutics CGT Drugs Product Portfolio

6.10.5 Orchard Therapeutics Recent Developments/Updates

6.11 Sequoia

6.11.1 Sequoia Company Information

6.11.2 Sequoia Description and Business Overview

6.11.3 Sequoia CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Sequoia CGT Drugs Product Portfolio

6.11.5 Sequoia Recent Developments/Updates

6.12 Fosun Kite Biotechnology

6.12.1 Fosun Kite Biotechnology Company Information

6.12.2 Fosun Kite Biotechnology Description and Business Overview

6.12.3 Fosun Kite Biotechnology CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Fosun Kite Biotechnology CGT Drugs Product Portfolio

6.12.5 Fosun Kite Biotechnology Recent Developments/Updates

6.13 Sunway Biotech

6.13.1 Sunway Biotech Company Information

6.13.2 Sunway Biotech Description and Business Overview

6.13.3 Sunway Biotech CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Sunway Biotech CGT Drugs Product Portfolio

6.13.5 Sunway Biotech Recent Developments/Updates

6.14 SiBiono

6.14.1 SiBiono Company Information

6.14.2 SiBiono Description and Business Overview

6.14.3 SiBiono CGT Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 SiBiono CGT Drugs Product Portfolio

6.14.5 SiBiono Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 CGT Drugs Industry Chain Analysis

7.2 CGT Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 CGT Drugs Production Mode & Process Analysis

7.4 CGT Drugs Sales and Marketing

7.4.1 CGT Drugs Sales Channels

7.4.2 CGT Drugs Distributors

7.5 CGT Drugs Customer Analysis

8 CGT Drugs Market Dynamics

8.1 CGT Drugs Industry Trends

8.2 CGT Drugs Market Drivers

8.3 CGT Drugs Market Challenges

8.4 CGT Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fosun Kite Biotechnology

List of Tables

Table 1. Global CGT Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global CGT Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global CGT Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global CGT Drugs Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global CGT Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global CGT Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global CGT Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market CGT Drugs Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of CGT Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of CGT Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of CGT Drugs, Product Type & Application

Table 12. Global Key Manufacturers of CGT Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global CGT Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global CGT Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global CGT Drugs Sales by Region (2020-2025) & (Tons)

Table 18. Global CGT Drugs Sales Market Share by Region (2020-2025)

Table 19. Global CGT Drugs Sales by Region (2026-2031) & (Tons)

Table 20. Global CGT Drugs Sales Market Share by Region (2026-2031)

Table 21. Global CGT Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global CGT Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global CGT Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global CGT Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America CGT Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America CGT Drugs Sales by Country (2020-2025) & (Tons)

Table 27. North America CGT Drugs Sales by Country (2026-2031) & (Tons)

Table 28. North America CGT Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America CGT Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe CGT Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe CGT Drugs Sales by Country (2020-2025) & (Tons)

Table 32. Europe CGT Drugs Sales by Country (2026-2031) & (Tons)

Table 33. Europe CGT Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe CGT Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific CGT Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific CGT Drugs Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific CGT Drugs Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific CGT Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific CGT Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America CGT Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America CGT Drugs Sales by Country (2020-2025) & (Tons)

Table 42. Latin America CGT Drugs Sales by Country (2026-2031) & (Tons)

Table 43. Latin America CGT Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America CGT Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa CGT Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa CGT Drugs Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa CGT Drugs Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa CGT Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa CGT Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global CGT Drugs Sales (Tons) by Type (2020-2025)

Table 51. Global CGT Drugs Sales (Tons) by Type (2026-2031)

Table 52. Global CGT Drugs Sales Market Share by Type (2020-2025)

Table 53. Global CGT Drugs Sales Market Share by Type (2026-2031)

Table 54. Global CGT Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global CGT Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global CGT Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global CGT Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global CGT Drugs Price (US$/Ton) by Type (2020-2025)

Table 59. Global CGT Drugs Price (US$/Ton) by Type (2026-2031)

Table 60. Global CGT Drugs Sales (Tons) by Application (2020-2025)

Table 61. Global CGT Drugs Sales (Tons) by Application (2026-2031)

Table 62. Global CGT Drugs Sales Market Share by Application (2020-2025)

Table 63. Global CGT Drugs Sales Market Share by Application (2026-2031)

Table 64. Global CGT Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global CGT Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global CGT Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global CGT Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global CGT Drugs Price (US$/Ton) by Application (2020-2025)

Table 69. Global CGT Drugs Price (US$/Ton) by Application (2026-2031)

Table 70. Janssen Biotech Company Information

Table 71. Janssen Biotech Description and Business Overview

Table 72. Janssen Biotech CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Janssen Biotech CGT Drugs Product

Table 74. Janssen Biotech Recent Developments/Updates

Table 75. Celgene Corporation Company Information

Table 76. Celgene Corporation Description and Business Overview

Table 77. Celgene Corporation CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Celgene Corporation CGT Drugs Product

Table 79. Celgene Corporation Recent Developments/Updates

Table 80. Juno Therapeutics Company Information

Table 81. Juno Therapeutics Description and Business Overview

Table 82. Juno Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Juno Therapeutics CGT Drugs Product

Table 84. Juno Therapeutics Recent Developments/Updates

Table 85. Kite Pharma Company Information

Table 86. Kite Pharma Description and Business Overview

Table 87. Kite Pharma CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Kite Pharma CGT Drugs Product

Table 89. Kite Pharma Recent Developments/Updates

Table 90. Novartis Company Information

Table 91. Novartis Description and Business Overview

Table 92. Novartis CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Novartis CGT Drugs Product

Table 94. Novartis Recent Developments/Updates

Table 95. Spark Therapeutics Company Information

Table 96. Spark Therapeutics Description and Business Overview

Table 97. Spark Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Spark Therapeutics CGT Drugs Product

Table 99. Spark Therapeutics Recent Developments/Updates

Table 100. Amgen Company Information

Table 101. Amgen Description and Business Overview

Table 102. Amgen CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Amgen CGT Drugs Product

Table 104. Amgen Recent Developments/Updates

Table 105. Bluebird Bio Company Information

Table 106. Bluebird Bio Description and Business Overview

Table 107. Bluebird Bio CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Bluebird Bio CGT Drugs Product

Table 109. Bluebird Bio Recent Developments/Updates

Table 110. GSK Company Information

Table 111. GSK Description and Business Overview

Table 112. GSK CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. GSK CGT Drugs Product

Table 114. GSK Recent Developments/Updates

Table 115. Orchard Therapeutics Company Information

Table 116. Orchard Therapeutics Description and Business Overview

Table 117. Orchard Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Orchard Therapeutics CGT Drugs Product

Table 119. Orchard Therapeutics Recent Developments/Updates

Table 120. Sequoia Company Information

Table 121. Sequoia Description and Business Overview

Table 122. Sequoia CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Sequoia CGT Drugs Product

Table 124. Sequoia Recent Developments/Updates

Table 125. Fosun Kite Biotechnology Company Information

Table 126. Fosun Kite Biotechnology Description and Business Overview

Table 127. Fosun Kite Biotechnology CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Fosun Kite Biotechnology CGT Drugs Product

Table 129. Fosun Kite Biotechnology Recent Developments/Updates

Table 130. Sunway Biotech Company Information

Table 131. Sunway Biotech Description and Business Overview

Table 132. Sunway Biotech CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Sunway Biotech CGT Drugs Product

Table 134. Sunway Biotech Recent Developments/Updates

Table 135. SiBiono Company Information

Table 136. SiBiono Description and Business Overview

Table 137. SiBiono CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. SiBiono CGT Drugs Product

Table 139. SiBiono Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. CGT Drugs Distributors List

Table 143. CGT Drugs Customers List

Table 144. CGT Drugs Market Trends

Table 145. CGT Drugs Market Drivers

Table 146. CGT Drugs Market Challenges

Table 147. CGT Drugs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of CGT Drugs

Figure 2. Global CGT Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CGT Drugs Market Share by Type: 2024 & 2031

Figure 4. CAR-T Therapy Product Picture

Figure 5. Viral Vector Therapy Product Picture

Figure 6. Stem Cell Therapy Product Picture

Figure 7. Oncolytic Virus Therapy Product Picture

Figure 8. Global CGT Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global CGT Drugs Market Share by Application: 2024 & 2031

Figure 10. Rare Disease

Figure 11. Tumor Disease

Figure 12. Eye Disease

Figure 13. Others

Figure 14. Global CGT Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global CGT Drugs Market Size (2020-2031) & (US$ Million)

Figure 16. Global CGT Drugs Sales (2020-2031) & (Tons)

Figure 17. Global CGT Drugs Average Price (US$/Ton) & (2020-2031)

Figure 18. CGT Drugs Report Years Considered

Figure 19. CGT Drugs Sales Share by Manufacturers in 2024

Figure 20. Global CGT Drugs Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest CGT Drugs Players: Market Share by Revenue in CGT Drugs in 2024

Figure 22. CGT Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global CGT Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America CGT Drugs Sales Market Share by Country (2020-2031)

Figure 25. North America CGT Drugs Revenue Market Share by Country (2020-2031)

Figure 26. United States CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe CGT Drugs Sales Market Share by Country (2020-2031)

Figure 29. Europe CGT Drugs Revenue Market Share by Country (2020-2031)

Figure 30. Germany CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific CGT Drugs Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific CGT Drugs Revenue Market Share by Region (2020-2031)

Figure 37. China CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Southeast Asia CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America CGT Drugs Sales Market Share by Country (2020-2031)

Figure 45. Latin America CGT Drugs Revenue Market Share by Country (2020-2031)

Figure 46. Mexico CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa CGT Drugs Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa CGT Drugs Revenue Market Share by Country (2020-2031)

Figure 51. Turkey CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE CGT Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of CGT Drugs by Type (2020-2031)

Figure 55. Global Revenue Market Share of CGT Drugs by Type (2020-2031)

Figure 56. Global CGT Drugs Price (US$/Ton) by Type (2020-2031)

Figure 57. Global Sales Market Share of CGT Drugs by Application (2020-2031)

Figure 58. Global Revenue Market Share of CGT Drugs by Application (2020-2031)

Figure 59. Global CGT Drugs Price (US$/Ton) by Application (2020-2031)

Figure 60. CGT Drugs Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions